Table 1.
General view of included clinical studies in terms of: approach, number of subjects and framework.
Approach/ Comparison |
Matrix/Sample | Cohort Size * | Patients (Smokers/Former/ Never) |
Controls (Smokers/Former/ Never) |
Organization | Reference |
---|---|---|---|---|---|---|
COPD vs. controls | mixed breath | 66 + 45 | 40/20/6 | 12/10/23 | University Hospital Maastricht; Centre for Integrated Rehabilitation Organ Failure, Horn, The Netherlands | [54] |
Asthma vs. controls (children) |
mixed breath | 63 + 57 | na | na | Department of Pediatric Pulmonology of University Hospital, Maastricht, Netherlands | [17] |
Asthma vs. controls | mixed + alveolar breath | 27 + 24 | all non-smokers | all non-smokers | Istituto Dermopatico dell’ Immacolata, Rome (Italy) | [55] |
Lung cancer vs. controls | mixed breath | 28 + 36 | 0/17/11 | 36 ^ | Forlanini Hospital, Roma, Italy. | [21] |
Lung cancer vs. never vs. smoker vs. controls | alveolar breath | 12 + 12 + 12 | 0/12/0 | 12//0/12 | Department of pulmonology, University Rostock, Rostock, Germany | [56] |
COPD vs. controls | alveolar breath | 20 + 6 | 18/2 ^ | 0/6 ^ | Medicines Evaluation Unit, Wythenshawe Hospital, Manchester, UK | [57] |
Lung cancer vs. never vs. smoker vs. controls | alveolar breath | 31 + 31 + 31 | 0/29/2 | 31/0/31 | Department of pneumology of local hospitals from Rostock, Germany and Innsbruck, Austria | [48] |
Lung cancer vs. controls | alveolar breath | 30 + 22 | not specified | not specified | Oncology Division, Rambam Health Care Campus, Haifa, Israel | [58] |
Lung cancer vs. non-smokers | mixed breath | 40 + 38 | 21/12/7 | 0/10/28 | Thoracic Surgery Section of the University Hospital of Parma, Italy | [59] |
Lung cancer vs. controls | mixed breath | 43 + 41 | 0/21/22 | 0/0/41 | Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. | [60] |
Asthma vs. control (children) |
mixed breath | 35 + 15 | na | na | Department of Paediatric Immunoalergology of Hospital D. Pedro, Aveiro, Portugal | [61] |
Asthma vs. controls | mixed breath + sputum | 35 + 23 | 0/1/34 | 0/0/23 | Medicines Evaluation Unit, Wythenshawe Hospital, Manchester, UK | [47] |
Emphysema/COPD vs. controls | alveolar breath | 43 + 161 | ns | ns | Institute for Molecules and Materials, Radboud University, Nijmegen, the Netherlands | [32] |
Asthma vs. COPD | mixed breath | 60 + 40 | No healthy controls | 5/51/4 COPD:13/0/27 |
Academic MC Amsterdam; Haga Teaching Hospital; Albert Schweitzer Hospital, Dordrecht, the Netherlands | [38] |
COPD with AATD vs. COPD vs. controls | exhaled breath condensate | 10 + 23 + 10 | 3/30/0 | 0/2/8 | Philipps University Marburg; Ludwig Maximilians University Munich; Saarland University Hospital, Homburg/Saar, Germany | [39] |
Lung cancer vs. controls | mixed breath | 23 + 30 | 2/0/21 | 6/0/24 | Department of Lung Disease, Collegium Medicum, Nicolaus Copernicus University, Torun, Poland | [62] |
Lung cancer vs. controls | alveolar breath | 137 + 143 | ns/ns/ns | 102/ns/41 | Department of Lung Disease, Collegium Medicum, Nicolaus Copernicus University, Torun, Poland | [22] |
Asthma vs. controls (children) |
mixed breath | 32 + 27 | na | na | The Hospital Infante D. Pedro E.P.E, Aveiro, Portugal | [46] |
COPD vs. controls | breath + sputum | 39 + 32 | 12/27/0 | 10/0/22 | Medicines Evaluation Unit, University Hospital of South Manchester, UK. | [63] |
COPD vs. COPD with BC vs. controls | alveolar breath | 30 + 54 + 35 | ns/ns/ns | ns/ns/ns | KIST Europe; Max Planck Institute; Cluster of Excellence for Multimodel Computing and Interaction; Saarland University, Germany | [35] |
COPD vs. controls | alveolar breath | 119 + 63 | 41/78/0 | 6/18/39 | Respiratory Unit, Prince Philip Hospital, Llanelli, UK | [14] |
COPD vs. asthma vs. controls | exhaled breath condensate | 17 + 20 + 7 | 5/16/16 | 0/3/4 | Patients recruited from hospital out-patient clinics; controls from the community in Sydney, Australia. | [40] |
Lung cancer vs. controls | alveolar breath | 29 + 44 | ns/ns/ns | ns/ns/ns | Department of Lung Disease, Collegium Medicum, Nicolaus Copernicus University, Torun, Poland | [44] |
Lung cancer vs. controls | mixed breath | 92 + 137 | 25/58/9 | 28/71/35 | Outpatient clinic from Cleveland Clinic, Cleveland, Ohio | [64] |
Asthma vs. controls (children) | alveolar breath | 11 + 12 | na | na | Inaccessible for authors; study developed in UK | [65] |
Asthma with exacerbation vs. asthma (children) | mixed breath | 16 + 26 | na | na | Outpatient clinic, Department of Pediatric Pulmonology, Maastricht University Medical Centre, Maastricht, the Netherlands | [45] |
Lung cancer vs. controls | mixed breath | 22 + 10 | 19 #/3 | 0/10 ^ | Local hospitals from Linköping, Sweden. | [66] |
Lung cancer vs. BPD vs. controls | mixed breath | 97 + 32 + 88 | ns/ns/ns | 45/43 ^ | James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky | [67] |
Asthma vs. controls | mixed breath | 195 + 40 | ns/ns/ns | ns/ns/ns | High Altitude Clinic, Davos-Wolfgang, Switzerland | [43] |
Lung cancer vs. BPD vs. controls | mixed breath | 107 + 40 + 88 | 56/65/12 | 45/0/43 | Unmentioned; study developed in Louisville, Kentucky | [68] |
Lung cancer vs. controls | mixed breath | 50 + 39 | 33 #/17 | 7 #/32 | St. Marianna University School of Medicine, Kanagawa, Japan | [36] |
Lung cancer vs. controls | mixed breath | 13 + 25 | ns/ns/ns | ns/ns/ns | Shanghai Chest Hospital, Shanghai, China | [69] |
Lung cancer vs. BPD vs. controls | alveolar breath | 79 + 54 + 38 | 15/40/24 | 9/20/9 12/25/17 (BPD) |
Sir Run Run Shaw Hospital, Hangzhou, China | [70] |
COPD vs. smoker vs. non-smoker controls | alveolar breath | 45 + 23 + 28 | 5/40/0 | 11/12/28 | Department of Pneumology, Ruhrlandklinik, University Hospital of Essen, Germany | [18] |
Lung cancer vs. BPD vs. smoker vs. non-smoker controls | mixed breath | 85 + 34 + 45 + 40 | 45/34/2/4 λ | 45/0/40 10/7/7/10 λ (BPD) |
James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky | [71] |
Lung cancer vs. controls | mixed breath | 13 + 25 | 5/8 ^ | 8/17 ^ | Shanghai Chest Hospital, Shanghai, China | [72] |
Lung cancer vs. BPD vs. controls | mixed breath | 165 + 65 + 194 | 69/80/7 | 25/20/20 (BPD) 73/41/80 | Unmentioned; study developed in Louisville, Kentucky | [73] |
COPD vs. controls | mixed breath | 89 + 101 | 37/52/0 | 49/52 ^ | Local hospitals in Marburg & Hannover, Germany. | [19] |
COPD vs. controls | alveolar breath | 79 + 73 | 42/37 ^ | 41/32 ^ | Unmentioned; study developed in Germany | [37] |
MPM vs. AEx vs. controls | alveolar breath | 23 + 22 + 21 | 9/5/9 (MPM) | 5/5/12 (AEx) 13/0/8 |
University Hospitals of Ghent, Leuven and Antwerp, Belgium | [74] |
Lung cancer vs. controls | mixed breath | 21 + 22 | 4/7/10 | 9/5/8 | Unmentioned; study developed (probably) in Israel | [33] |
Lung cancer vs. controls | mixed breath | 37 + 23 | 21/14/2 | 4/7/12 | ELK Berlin Chest Hospital and Charité Universitäts Medizin, Visceral, Vascular and Thoracic Surgery, Berlin, Germany | [75] |
Asthma vs. asthma with exacerbations (children) | mixed breath | 49 + 45 | na | na | Outpatient clinic of 2 specialized pediatric pulmonology centers in the Netherlands | [76] |
Lung cancer vs. BPD | alveolar breath | 89 + 30 | 16/56/17 | 14/10/6 | Sheba Medical Center, Tel Hashomer, Israel. | [77] |
MPM vs. AEx vs. controls | mixed breath | 14 + 19 + 16 | 1/9/4 | 6/7/6 (AEx) 0/8/8 | Three participating university hospitals from Belgium | [78] |
COPD vs. never vs. former vs. smokers | alveolar breath | 57+ 33 + 28 + 39 | 8/49/0 | 32/28/39 | Hospital Central de la Defensa “Gomez Ulla”, Madrid, Spain | [79] |
Lung cancer vs. controls | mixed breath | 116 + 37 | 42/51/23 | 2/5/30 | Tokai University Hospital, Kanagawa, Japan | [80] |
Lung cancer vs. controls | alveolar breath | 107 + 29 | 47/15/45 | 5/3/21 | Aichi Cancer center, Nagoya Japan | [16] |
AECOPD vs. COPD vs. controls | alveolar breath | 14 + 16 + 24 | 6/7/1 (AECOP) | 3/13/0 (COPD) 7/0/17 |
Department of Internal Medicine II, Medical University of Innsbruck, Austria | [81] |
COPD vs. controls | exhaled breath condensate | 22 + 14 | 10/11/1 | 5/8/1 | Unmentioned; study developed in Switzerland | [20] |
Lung cancer vs. BPD vs. controls | alveolar breath | 233+ 111 + 140 | 102/45/86 | 41/16/54 (BPD) 69/16/55 |
Sir Run Run Shaw Hospital, Hangzhou, China | [82] |
Lung cancer vs. controls | alveolar breath | 37 + 48 | 9/15/13 | 4/10/34 | Seoul National University Bundang Hospital, Republic of Korea | [15] |
Lung cancer vs. controls | mixed breath | 57 + 72 | 22/35 ^ | 25/47 ^ | First Affiliated Hospital of Jinan University, Guangdong, China | [41] |
Lung cancer vs. COPD vs. controls | mixed breath | 30 + 18 + 61 | 12/16/2 | 10/8/0 (COPD) 13/21/27 |
Hospital Clinic and Hospital Universitari Sagrat Cor of Barcelona, Spain. | [83] |
Lung cancer vs. controls | mixed breath | 30 +30 | 19/11 ^ | 5/25 ^ | Chinese People’s Liberation Army General Hospital, Beijing, China | [34] |
Lung cancer vs. controls | alveolar breath | 108 + 121 | 69/39 ^ | 50/71 ^ | Department of Lung Disease, Collegium Medicum, Nicolaus Copernicus University, Torun, Poland | [84] |
Asthma vs. CF vs. controls (children) | mixed breath | 20 + 13 + 22 | na | na | Maastricht UMC & Department of Paediatric Respiratory Medicine, Maastricht, Netherlands | [42] |
COPD vs. controls | mixed breath | 25 + 33 | 4/10/11 | 3/7/23 | Outpatient clinic in Hospital Central “Dr. Ignacio Morones Prieto”, San Luis Potosi, Mexico | [85] |
Lung cancer vs. controls | alveolar breath | 462 | ns/ns/ns | ns/ns/ns | five medical centers in USA | [86] |
Lung cancer vs. controls | mixed breath | 15 + 14 | 3/12/0 | 1/6/7 | University hospital of Liège, Belgium | [13] |
* the numbers presented are connected with the categories of diseased patients or controls involved in the study (the first number refers to patients and the second to controls); #—former + active smokers; ^—former + never smokers; λ—smoking status unknown; AECOPD = acute exacerbation chronic obstructive pulmonary disease; AEx = asymptomatic former asbestos; BC = bronchial carcinoma; BPD = benign pulmonary diseases; CF—cystic fibrosis; MPM = malignant pleural mesothelioma (tumor of pleural lining of the thorax associated with asbestos exposure).